Calamos Advisors’s Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share FVIV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$4K 1583
2022
Q3
$4K Buy
+25,000
New +$4.1K ﹤0.01% 1228

Calamos Advisors's FVIV.WS Position: Q4 2022 in Review

Calamos Advisors sold out of Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (FVIV.WS) in Q4 2022, closing a stake of 25,000 shares — an estimated $4K sold.

Calamos Advisors first reported a position in FVIV.WS in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 0 funds tracked by Wall St. Rank hold FVIV.WS as of Q4 2022.

  • Calamos Advisors reported no remaining Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Calamos Advisors sold 25,000 Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $4K.
  • Calamos Advisors first reported a position in Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q3 2022 and held it in 1 quarter.
  • Calamos Advisors's Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $4K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.